Download PDF
Schlaf 2018; 07(02): 90-94
DOI: 10.1055/s-0038-1660950
Review/Original
Schattauer GmbH

Schlafstörungen als Nebenwirkungen von Psychopharmaka

Corinna Frohn
Further Information

Publication History

Publication Date:
07 June 2018 (online)

    Permissions and Reprints

Schlafstörungen treten oft als ein Symptom psychischer Erkrankungen auf (3). Dem stehen Schlafstörungen, die durch die Einnahme von Psychopharmaka verursacht werden, gegenüber. Teilweise sind Nebenwirkungen von Medikamenten sehr offensichtlich, und Beschwerden werden bereits vom Patienten selbst mit der Medikation in Zusammenhang gebracht. Teils ist die Symptomatik jedoch erst durch eine genaue psychiatrische Anamnese mit der Medikation in Verbindung zu bringen.

 

  • Literatur

  • 1 Benkert, Hippius: Kompendium der Psychiatrischen Pharmakotherapie, 8. Auflage. Springer Verlag; DOI 10.1007/978–3–642–29809–7.
    Google Scholar
  • 2 Mirtazapine induces nightmares in depressed patients / Nightmares by mirtazapine (PHP-2017–02–0642). Pharmacopsychiatry. 2017 50. 161 DOI: 10.1055/s-0043-–105076.
    PubMedGoogle Scholar
  • 3 S3-Leitlinie Nicht erholsamer Schlaf/Schlafstörungen, Deutsche Gesellschaft für Schlafforschung und Schlafmedizin (DGSM). Somnologie. 2009 13. 4-160 DOI 10.1007/s11818–009–0430–8.
    PubMedGoogle Scholar
  • 4 Citrome L. Activating and Sedating Adverse Effects of Second-Generation Antipsychotics in the Treatment of Schizophrenia and Major Depressive Disorder: Absolute Risk Increase and Number Needed to Harm. J Clin Psychopharmacol. 2017 37. (02): 138-147 doi: 10.1097/JCP.0000000000000665.
    PubMedGoogle Scholar
  • 5 Ghori AK, Sajatovic M, Tampi RR. A Case of Emergent Restless Legs Syndrome With Lurasidone Therapy. J Clin Psychopharmacol. 2016 36. (03): 293-4 doi: 10.1097/JCP.0000000000000496.
    PubMedGoogle Scholar
  • 6 Güneş S, Camkurt MA. Sleep-Related Eating Disorder Associated With Risperidone: An Adolescent Case. J Clin Psychopharmacol. 2016 36. (03): 286-8 doi: 10.1097/JCP.0000000000000502.
    PubMedGoogle Scholar
  • 7 Alberti S, Chiesa A, Andrisano C, Serretti A. Insomnia and somnolence associated with second-generation antidepressants during the treatment of major depression: a meta-analysis. J Clin Psychopharmacol. 2015 35. (03): 296-303 doi: 10.1097/JCP.0000000000000329.
    PubMedGoogle Scholar
  • 8 American Academy of Sleep Medicine: The International Classification of Sleep Disorders. Third Edition (ICSD-3). Darien: 2014
    Google Scholar
  • 9 World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. WHON; Geneva: 2017
    Google Scholar
  • 10 Schroeck JL, Ford J, Conway EL, Kurtzhalts KE, Gee ME, Vollmer KA, Mergenhagen KA. Review of Safety and Efficacy of Sleep Medicines in Older Adults. Clin Ther. 2016 38. (11): 2340-2372 doi: 10.1016/j.clinthera.2016.09.010. Epub 2016 Oct 15.
    PubMedGoogle Scholar
  • 11 Sangal RB, Owens J, Allen AJ, Sutton V, Schuh K, Kelsey D. Effects of atomoxetine and methylphenidate on sleep in children with ADHD. Sleep 2006; 29 (12) 1573-85.
    CrossrefPubMedGoogle Scholar
  • 12 Bellon A, Coverdale JH. Delirium, thrombocytopenia, insomnia, and mild liver damage associated with MAOI withdrawal. Eur J Clin Pharmacol. 2009 65. (12): 1269-70 doi: 10.1007/s00228–009–0711-y.
    PubMedGoogle Scholar
  • 13 Kolla BP, Mansukhani MP, Bostwick JM. The influence of antidepressants on restless legs syndrome and periodic limb movements: A systematic review. Sleep Med Rev. 2017 pii:S1087–0792(17)30124–7. doi: 10.1016/j.smrv.2017.06.002. [Epub ahead of print].
    PubMedGoogle Scholar
  • 14 Wichniak A, Wierzbicka A, Walęcka M, Jernajczyk W. Effects of Antidepressants on Sleep. Curr Psychiatry Rep 2017; 19 (09) 63 doi: 10.1007/s11920–017–0816–4.
    CrossrefPubMedGoogle Scholar
  • 15 Iversen TSJ, Steen NE, Dieset I, Hope S, Mørch R, Gardsjord ES, Jørgensen KN, Melle I, Andreassen OA, Molden E, Jönsson EG. Side effect burden of antipsychotic drugs in real life – Impact of gender and polypharmacy. Prog Neuropsychopharmacol Biol Psychiatry. 2017 pii: S0278–5846(17)30627–9. doi: 10.1016/j.pnpbp.2017.11.004. [Epub ahead of print].
    PubMedGoogle Scholar
  • 16 Lee K, Baron K, Soca R, Attarian H. The Prevalence and Characteristics of REM Sleep without Atonia (RSWA) in Patients Taking Antidepressants. J Clin Sleep Med. 2016 12. (03): 351-5 doi: 10.5664/jcsm.5582.
    PubMedGoogle Scholar